subject area of
- A brief survey of clinicians’ perceptions of parent preferences for involvement in obstetrical and perinatal management decisions in haemophilia Journal Articles
- A case of non‐resolving hemophilia B Leyden in a 42‐year‐old male (F9 promoter + 13 A>G) Journal Articles
- A pilot randomized control trial to evaluate the feasibility of an Internet‐based self‐management and transitional care program for youth with haemophilia Journal Articles
- A preliminary application of a haemophilia value framework to emerging therapies in haemophilia Journal Articles
- A study of variations in the reported haemophilia B prevalence around the world Journal Articles
- A systematic review of definitions and reporting of bleeding outcome measures in haemophilia Journal Articles
- A therapeutic alternative for haemophiliacs with inhibitors Journal Articles
- Abnormal hemostasis in a knock‐in mouse carrying a variant of factor IX with impaired binding to collagen type IV Journal Articles
- An important role for the activation peptide domain in controlling factor IX levels in the blood of haemophilia B mice Conferences
- Association of factor expression levels with health-related quality of life and direct medical costs for people with haemophilia B Journal Articles
- Cardiac surgery in patients with haemophilia B: a case report and review of the literature Journal Articles
- Cardiovascular disease (CVD) in Canadians with haemophilia: Age‐Related CVD in Haemophilia Epidemiological Research (ARCHER study) Journal Articles
- Cardiovascular disease prevalence and relevance in haemophilia: a scoping review Journal Articles
- Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B Journal Articles
- Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B Journal Articles
- Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B Journal Articles
- Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B Journal Articles
- Comparing bleed frequency and factor concentrate use between haemophilia A and B patients Journal Articles
- Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the 2 coagulation disorders Journal Articles
- Continuous Infusion of Factor Concentrates: Review of Use in Hemophilia A and Demonstration of Safety and Efficacy in Hemophilia B Conferences
- Continuous intravenous infusion of a plasma‐derived factor IX concentrate (Mononine®) in haemophilia B Journal Articles
- Continuous prophylaxis with recombinant factor IX Fc fusion protein and conventional recombinant factor IX products: comparisons of efficacy and weekly factor consumption Journal Articles
-
Core outcome set for gene therapy in haemophilia: Results of the core
HEM multistakeholder project Journal Articles - Delivery of human factor IX in mice by encapsulated recombinant myoblasts: a novel approach towards allogeneic gene therapy of hemophilia B Journal Articles
- Developing a two‐sided intervention to facilitate shared decision‐making in haemophilia: decision boxes for clinicians and patient decision aids for patients Journal Articles
- Differences between patients’, physicians’ and pharmacists’ preferences for treatment products in haemophilia: a discrete choice experiment Journal Articles
- Does an enzyme other than thrombin contribute to unexpected changes in the levels of the different forms of thrombin activatable fibrinolysis inhibitor in patients with hemophilia A, hemophilia B and von Willebrand disease? Journal Articles
- Efficacy of a high purity, chemically treated and nanofiltered factor IX concentrate for continuous infusion in haemophilia patients undergoing surgery Journal Articles
- Encapsulated human primary myoblasts deliver functional hFIX in hemophilic mice Journal Articles
- Estimating and interpreting the pharmacokinetic profiles of individual patients with hemophilia A or B using a population pharmacokinetic approach: communication from the SSC of the ISTH Journal Articles
- Evaluation of the sexual health in people living with hemophilia Journal Articles
- Evolution of haemophilia integrated care in the era of gene therapy: Treatment centre’s readiness in United States and EU Journal Articles
- Expression of Human Factor IX by Microencapsulated Recombinant Fibroblasts Journal Articles
- Factor IX pharmacokinetics: differences between plasma‐derived and recombinant products and the clinical and economic implications: a meeting report Conferences
- Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B. Journal Articles
- HIV Infection in a Defined Population of Swedish Haemophiliacs Journal Articles
- Haemophilia Experiences, Results and Opportunities (HERO) Study: survey methodology and population demographics Journal Articles
- Hemophilia B (Christmas disease) variants and carrier detection analyzed by DNA probes. Journal Articles
- Hemophilia gene therapy: first, do no harm Journal Articles
- Hepatitis E virus infection in hemophiliacs Journal Articles
- Hepatitis, Epidemiology and Liver Function in Hemophiliacs in Sweden Journal Articles
- High adherence to prophylaxis regimens in haemophilia B patients receiving rIX‐FP: Evidence from clinical trials and real‐world practice Journal Articles
- Immune tolerance induction for a patient with factor IX inhibitors - a case report Journal Articles
- Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or B Journal Articles
- Immunoglobulin levels in haemophiliacs at HIV seroconversion and during follow up Journal Articles
- Inhibitor development in haemophilia according to concentrate Journal Articles
- Inhibitor development in non-severe haemophilia across Europe Journal Articles
- Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitors Journal Articles
-
Joint
WFH ‐ISTH session: issues in clinical trial design Journal Articles - Joint Bleeding Tendencies in Adult Patients With Hemophilia: It’s Not All Pharmacokinetics Journal Articles
- Limited Protective Effect of the CCR5Δ32/CCR5Δ32 Genotype on Human Immunodeficiency Virus Infection Incidence in a Cohort of Patients with Hemophilia and Selection for Genotypic X4 Virus Journal Articles
- Long-acting recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in children Journal Articles
- Low prevalence of inhibitor antibodies in the Canadian haemophilia population Journal Articles
-
Methodologies for data collection in congenital haemophilia with inhibitors (
CH wI): critical assessment of the literature and lessons learned from recombinant factorVII a Journal Articles - More on: are randomized clinical trials the only truth? Not always Journal Articles
- Mortality and causes of death in Italian persons with haemophilia, 1990–2007 Journal Articles
- Mutation Analysis in F9 Gene of 17 Families with Haemophilia B from Iran Conferences
- On‐demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: differences in treatment characteristics and outcome Journal Articles
- Orthotopic liver transplantation in a patient with combined hemophilia A and B Journal Articles
- Outcomes indicators and processes in transitional care in adolescents with haemophilia: A Delphi survey of Canadian haemophilia care providers Journal Articles
-
Patterns of tertiary prophylaxis in
C anadian adults with severe and moderately severe haemophiliaB Journal Articles - Persistent Delivery of Factor IX in Mice: Gene Therapy for Hemophilia Using Implantable Microcapsules Journal Articles
- Pharmacokinetics of recombinant and plasma-derived factor IX products in pediatric patients with severe hemophilia B Journal Articles
- Prevalence of hepatitis C virus infection among patients with inherited bleeding disorders in Newfoundland. Journal Articles
- Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized Journal Articles
- Propagating factor IX-producing hepatocytes for haemophilia B therapy Journal Articles
- Prophylaxis use of clotting factor replacement products in people with non‐severe haemophilia: A review of the literature Journal Articles
- Recombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors Journal Articles
- Redefining Disease? The Nosologic Implications of Molecular Genetic Knowledge Journal Articles
- Replacement therapy with recombinant factor IX. A multicentre evaluation of current dosing practices in Italy. Journal Articles
- Shared topics on the experience of people with haemophilia living in the UK and the USA and the influence of individual and contextual variables: Results from the HERO qualitative study Journal Articles
- Survey of the Canadian hemophilia population. Journal Articles
- Sustained and therapeutic delivery of factor IX in nude haemophilia B mice by encapsulated C2C12 myoblasts: concurrent tumourigenesis Journal Articles
- Sustained and therapeutic levels of human factor IX in hemophilia B mice implanted with microcapsules: key role of encapsulated cells Journal Articles
- Sustained expression of coagulation factor IX by modified cord blood‐derived mesenchymal stromal cells Journal Articles
- Switching patients in the age of long-acting recombinant products? Journal Articles
- Tailoring treatment of haemophilia B: accounting for the distribution and clearance of standard and extended half-life FIX concentrates Journal Articles
- The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas. Journal Articles
- The current state of adverse event reporting in hemophilia Journal Articles
- The plasma concentration of activated protein C appears normal in patients with haemophilia Journal Articles
- The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis survey Journal Articles
- Treatment decision‐making among Canadian youth with severe haemophilia: a qualitative approach Journal Articles
- Treatment of hemophilia B in mice with nonautologous somatic gene therapeutics Journal Articles
- Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disorders Journal Articles
- Validation of a composite score for clinical severity of hemophilia Journal Articles
-
What should men living with haemophilia need to know? The perspectives of
C anadian men with haemophilia Journal Articles - [Centralized care is the basis of care programs for hemophilia patients]. Journal Articles
- [Cure of hemophilia is approaching. Gene therapy is the hope]. Journal Articles